Zobrazeno 1 - 10
of 1 617
pro vyhledávání: '"Gabe, S."'
Autor:
Gabe S Sonke, Amos J de Jong, Lourens T Bloem, Christine C van Hattem, Jolien S de Groot, Jarno Hoekman, K Esther Broekman, Paula B van Hennik
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Objective The collection of comprehensive data from post-authorisation trials for conditionally authorised anticancer medicines is frequently delayed. This raises questions about the feasibility of post-authorisation randomised controlled trials (RCT
Externí odkaz:
https://doaj.org/article/4fe87bd87ee346fdb277817cb56dabf2
Autor:
Donna O. Debets, Erik L. de Graaf, Marte C. Liefaard, Gabe S. Sonke, Esther H. Lips, Anna Ressa, Maarten Altelaar
Publikováno v:
iScience, Vol 27, Iss 6, Pp 109858- (2024)
Summary: In this study, we measured the kinase activity profiles of 32 pre-treatment tumor biopsies of HER2-positive breast cancer patients. The aim of this study was to assess the prognostic potential of kinase activity levels, to identify potential
Externí odkaz:
https://doaj.org/article/bfdbc26b61c74528a8ee376a35d970f6
Autor:
Tannock, Ian F *, Buyse, Marc, De Backer, Mickael, Earl, Helena, Goldstein, Daniel A, Ratain, Mark J, Saltz, Leonard B, Sonke, Gabe S, Strohbehn, Garth W
Publikováno v:
In The Lancet Oncology October 2024 25(10):e520-e525
Autor:
Hoog, Catharina J P Op ‘t, Mehra, Niven, Maliepaard, Marc, Bol, Kalijn, Gelderblom, Hans, Sonke, Gabe S, de Langen, Adrianus J, van de Donk, Niels W C J, Janssen, Jeroen J W M, Minnema, Monique C, van Erp, Nielka P *, Boerrigter, Emmy
Publikováno v:
In The Lancet Oncology August 2024 25(8):e340-e351
Autor:
Ignatiadis, Michail, Poulakaki, Fiorita, Spanic, Tanja, Brain, Etienne, Lacombe, Denis, Sonke, Gabe S., Vincent-Salomon, Anne, Van Duijnhoven, Frederieke, Meattini, Icro, Kaidar-Person, Orit, Aftimos, Philippe, Lecouvet, Frederic, Cardoso, Fatima, Retèl, Valesca P., Cameron, David
Publikováno v:
In European Journal of Cancer August 2024 207
Autor:
Hogervorst, Milou A., van Hattem, Christine C., Sonke, Gabe S., Mantel-Teeuwisse, Aukje K., Goettsch, Wim G., Bloem, Lourens T.
Publikováno v:
In Drug Discovery Today July 2024 29(7)
Autor:
Debets, Donna O., de Graaf, Erik L., Liefaard, Marte C., Sonke, Gabe S., Lips, Esther H., Ressa, Anna, Altelaar, Maarten
Publikováno v:
In iScience 21 June 2024 27(6)
Autor:
Tessa G. Steenbruggen, Denise M. Wolf, Michael J. Campbell, Joyce Sanders, Sten Cornelissen, Bram Thijssen, Roberto A. Salgado, Christina Yau, Nick O-Grady, Amrita Basu, Rajith Bhaskaran, Lorenza Mittempergher, Gillian L. Hirst, Jean-Philippe Coppe, Marleen Kok, Gabe S. Sonke, Laura J. van ‘t Veer, Hugo M. Horlings
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-19 (2023)
Abstract Background Despite major improvements in treatment of HER2-positive metastatic breast cancer (MBC), only few patients achieve complete remission and remain progression free for a prolonged time. The tumor immune microenvironment plays an imp
Externí odkaz:
https://doaj.org/article/cd4ee360474c49639be138517e337159
Autor:
Sonja Vliek, Florentine S. Hilbers, Erik van Werkhoven, Ingrid Mandjes, Rob Kessels, Sieta Kleiterp, Esther H. Lips, Lennart Mulder, Mutamba T. Kayembe, Claudette E. Loo, Nicola S. Russell, Marie-Jeanne T. F. D. Vrancken Peeters, Marjo J. Holtkamp, Margaret Schot, Joke W. Baars, Aafke H. Honkoop, Annelie J. E. Vulink, Alex L. T. Imholz, Suzan Vrijaldenhoven, Franchette W. P. J. van den Berkmortel, Jetske M. Meerum Terwogt, Jolanda G. Schrama, Philomeen Kuijer, Judith R. Kroep, Annemieke van der Padt-Pruijsten, Jelle Wesseling, Gabe S. Sonke, Kenneth G. A. Gilhuijs, Agnes Jager, Petra Nederlof, Sabine C. Linn
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-9 (2023)
Abstract Exploratory analyses of high-dose alkylating chemotherapy trials have suggested that BRCA1 or BRCA2-pathway altered (BRCA-altered) breast cancer might be particularly sensitive to this type of treatment. In this study, patients with BRCA-alt
Externí odkaz:
https://doaj.org/article/8df2c3c9b54e4fdaa94ca1a2ca82efc6
Autor:
van Leeuwen-Stok, E., van Leeuwen, L., de Graaf, H., van Riel, J.M.G.H., Houtsma, D., Vrijaldenhoven, S., van der Velden, A.W.G., Peerdeman, A.L., van den Brink - Schimmel, R.J., Drooger, J.C., Imholz, A.L.Th., Dercksen, M.W., Oulad Hadj, J., Bakker, S.D., van der Wouw, A.J., Kerver, E.D., Bouma, G., van Schaik, C., de Boer, M., Mandigers, C.M.P.W., Koornstra, R.H.T., Smals, A., Rietbroek, R.C., van der Padt - Pruijsten, A., den Boer, M.O., Bos, H., Schiphorst, P.P.J.B.M., Vriens, B.E.P.J., van Rossum, Q.C., Tol, J., Hoogwerf - Kluft, D., Kruijtzer - Schimmel, C.M.F., Oosterkamp, H.M., Baas, I.O., Dietvorst, A.H.P., Davidis - van Schoonhoven, M., van Dijk, M.A., van der Voort, Anna, Louis, Fleur M, van Ramshorst, Mette S, Kessels, Rob, Mandjes, Ingrid A, Kemper, Inge, Agterof, Mariette J, van der Steeg, Wim A, Heijns, Joan B, van Bekkum, Marlies L, Siemerink, Ester J, Kuijer, Philomeen M, Scholten, Astrid, Wesseling, Jelle, Vrancken Peeters, Marie-Jeanne T F D, Mann, Ritse M, Sonke, Gabe S *
Publikováno v:
In The Lancet Oncology May 2024 25(5):603-613